StreetInsider.com News Articles

AVITA Medical to Announce Second Quarter 2026 Financial Results

Tue, 14 Jul 2026 16:05:00 -0400

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

Second Quarter 2026 Webcast

AVITA Medical to Announce Second Quarter 2026 Financial Results

Tue, 14 Jul 2026 16:05:00 -0400

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

Second Quarter 2026 Webcast

AVITA Medical to Announce Second Quarter 2026 Financial Results

Tue, 14 Jul 2026 16:05:00 -0400

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

Second Quarter 2026 Webcast

AVITA Medical to Announce Second Quarter 2026 Financial Results

Tue, 14 Jul 2026 16:05:00 -0400

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

Second Quarter 2026 Webcast

AVITA Medical to Announce Second Quarter 2026 Financial Results

Tue, 14 Jul 2026 16:05:00 -0400

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

Second Quarter 2026 Webcast

AVITA Medical to Announce Second Quarter 2026 Financial Results

Tue, 14 Jul 2026 16:05:00 -0400

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 7, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

Second Quarter 2026 Webcast

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients

Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow

RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

Form 4 AVITA Medical, Inc. For: Jun 12 Filed by: O'Toole David D

Fri, 12 Jun 2026 16:30:00 -0400
si-local-file:///var/storage/secattach/20260612/26641335.html

Form 4 AVITA Medical, Inc. For: Jun 12 Filed by: O'Toole David D

Fri, 12 Jun 2026 16:30:00 -0400
si-local-file:///var/storage/secattach/20260612/26641335.html

Form 4 AVITA Medical, Inc. For: Jun 09 Filed by: Woody Joseph Fralin

Wed, 10 Jun 2026 21:17:00 -0400
si-local-file:///var/storage/secattach/20260610/26631391.html

Form 4 AVITA Medical, Inc. For: Jun 09 Filed by: Woody Joseph Fralin

Wed, 10 Jun 2026 21:17:00 -0400
si-local-file:///var/storage/secattach/20260610/26631391.html

Form 4 AVITA Medical, Inc. For: Jun 09 Filed by: Woody Joseph Fralin

Tue, 09 Jun 2026 16:58:00 -0400
si-local-file:///var/storage/secattach/20260609/26624528.html

Form 4 AVITA Medical, Inc. For: Jun 09 Filed by: Woody Joseph Fralin

Tue, 09 Jun 2026 16:58:00 -0400
si-local-file:///var/storage/secattach/20260609/26624528.html

Form 8-K AVITA Medical, Inc. For: Jun 05

Mon, 08 Jun 2026 06:01:00 -0400
si-local-file:///var/storage/secattach/20260608/26613731.html

Form 8-K AVITA Medical, Inc. For: Jun 05

Mon, 08 Jun 2026 06:01:00 -0400
si-local-file:///var/storage/secattach/20260608/26613731.html

Form 8-K AVITA Medical, Inc. For: Jun 05

Mon, 08 Jun 2026 06:01:00 -0400
si-local-file:///var/storage/secattach/20260608/26613731.html